Taiwan
· Delayed Price · Currency is TWD Sinew Pharma Statistics
Total Valuation
Sinew Pharma has a market cap or net worth of TWD 3.40 billion. The enterprise value is 2.24 billion.
| Market Cap | 3.40B |
| Enterprise Value | 2.24B |
Important Dates
The last earnings date was Thursday, March 20, 2025.
| Earnings Date | Mar 20, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Sinew Pharma has 71.31 million shares outstanding. The number of shares has increased by 1.22% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 71.31M |
| Shares Change (YoY) | +1.22% |
| Shares Change (QoQ) | +0.05% |
| Owned by Insiders (%) | 13.97% |
| Owned by Institutions (%) | 3.26% |
| Float | 45.13M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 2.84 |
| P/TBV Ratio | 2.89 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -14.91 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -21.10 |
Financial Position
The company has a current ratio of 43.46, with a Debt / Equity ratio of 0.00.
| Current Ratio | 43.46 |
| Quick Ratio | 43.43 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.03 |
| Interest Coverage | -407.88 |
Financial Efficiency
Return on equity (ROE) is -11.93% and return on invested capital (ROIC) is -8.33%.
| Return on Equity (ROE) | -11.93% |
| Return on Assets (ROA) | -8.15% |
| Return on Invested Capital (ROIC) | -8.33% |
| Return on Capital Employed (ROCE) | -14.08% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -2.89M |
| Employee Count | 52 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -29.93% in the last 52 weeks. The beta is 0.98, so Sinew Pharma's price volatility has been similar to the market average.
| Beta (5Y) | 0.98 |
| 52-Week Price Change | -29.93% |
| 50-Day Moving Average | 50.89 |
| 200-Day Moving Average | 58.45 |
| Relative Strength Index (RSI) | 37.56 |
| Average Volume (20 Days) | 43,651 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -168.86M |
| Pretax Income | -150.37M |
| Net Income | -150.37M |
| EBITDA | -144.98M |
| EBIT | -168.86M |
| Earnings Per Share (EPS) | -2.11 |
Balance Sheet
The company has 1.16 billion in cash and 2.82 million in debt, giving a net cash position of 1.16 billion or 16.21 per share.
| Cash & Cash Equivalents | 1.16B |
| Total Debt | 2.82M |
| Net Cash | 1.16B |
| Net Cash Per Share | 16.21 |
| Equity (Book Value) | 1.20B |
| Book Value Per Share | 16.79 |
| Working Capital | 1.15B |
Cash Flow
In the last 12 months, operating cash flow was -106.08 million and capital expenditures -179,000, giving a free cash flow of -106.26 million.
| Operating Cash Flow | -106.08M |
| Capital Expenditures | -179,000 |
| Free Cash Flow | -106.26M |
| FCF Per Share | -1.49 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Sinew Pharma does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.22% |
| Shareholder Yield | -1.22% |
| Earnings Yield | -4.43% |
| FCF Yield | -3.13% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |